Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Leukoc Biol ; 49(6): 566-78, 1991 Jun.
Article in English | MEDLINE | ID: mdl-1673992

ABSTRACT

The accumulation of mononuclear phagocytes at sites of chronic inflammation is dependent on an increase in the rate of extravasation of blood-borne monocytes through the vascular endothelium into the connective tissue. Once the monocytes have emigrated into the connective tissue, they may differentiate into tissue macrophages, presumably following interactions with extracellular matrix proteins. To study these processes, we tested the effects of cytokines and phorbol esters on the adhesion of U937 cells, a human monocyte-like cell line, to cultured endothelial cells (EC) and to matrix proteins. In the absence of cytokines, very few of the U937 cells adhered to EC (5% or less in most experiments). When EC were pretreated for optimal periods of time (4-8 hr) with recombinant interleukin-1 alpha (IL-1 alpha), IL-1 beta, tumor necrosis factor-alpha (TNF alpha), or lymphotoxin (LT; also known as TNF-beta), 35-85% of the U937 cells were able to bind. Interferon-gamma (IFN-gamma) and interleukin-2 (IL-2) did not stimulate U937-EC binding, even though IFN-gamma was shown to increase EC adhesiveness for T lymphocytes. Phorbol esters also greatly stimulated U937-EC adhesion but, in this case, the increase was due to an action on the U937 cells. A monoclonal antibody (MAb), 60.3, against the CD11/CD18 family of leukocyte adhesion molecules partially inhibited the adhesion of untreated and phorbol ester-treated U937 cells to noncytokine-treated EC. However, that MAb had no effect on U937 cell binding to TNF-alpha-treated EC. Thus U937 cells use both CD11/CD18-dependent and -independent mechanisms to adhere to EC. In the absence of stimulating agents, only a small proportion of the U937 cells (2-20%) adhered to fibronectin (FN), and almost none bound to either laminin (LN) or gelatin (denatured type I collagen). In the presence of phorbol esters, a much larger proportion of the U937 cells adhered to FN, with only slight increases in the proportion of cells which bound to LN or gelatin. Additional adhesion assays performed in the presence of a pentapeptide containing the amino acid sequence arg-gly-asp (RGD), which is part of one of the cell-binding domains of FN, demonstrated that the RGD-containing peptide almost totally blocked the phorbol ester-induced adhesion of U937 cells to FN. In contrast, the peptide had no inhibitory effect on the phorbol ester-induced binding of U937 cells to EC.


Subject(s)
Endothelium, Vascular/cytology , Extracellular Matrix Proteins/metabolism , Interferon-gamma/pharmacology , Interleukin-1/pharmacology , Monocytes/cytology , Phorbol Esters/pharmacology , Tumor Necrosis Factor-alpha/pharmacology , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/metabolism , Antigens, Differentiation/physiology , CD11 Antigens , CD18 Antigens , Cell Adhesion/physiology , Cell Line , Endothelium, Vascular/metabolism , Endothelium, Vascular/physiology , Fibroblasts/cytology , Fibroblasts/metabolism , Fibroblasts/physiology , Fibronectins/metabolism , Gelatin/metabolism , Humans , Laminin/metabolism , Ligands , Monocytes/metabolism , Monocytes/physiology , Oligopeptides/pharmacology , Receptors, Leukocyte-Adhesion/physiology , Recombinant Proteins/pharmacology
2.
J Cell Physiol ; 142(3): 488-95, 1990 Mar.
Article in English | MEDLINE | ID: mdl-1690212

ABSTRACT

Neovascularization, a common occurrence in chronic inflammatory lesions, requires endothelial cell (EC) proliferation. Because this form of inflammation is often mediated by immunologically generated cytokines, the effects of such cytokines on human umbilical vein EC proliferation in vitro were investigated. Low concentrations of recombinant interferon gamma (rIFN-gamma) (10-100 U/ml), but not a higher concentration (1,000 U/ml), enhanced both basal and endothelial cell growth factor (ECGF)-stimulated EC proliferation. Recombinant interleukin 1 (rIL-1) and recombinant tumor necrosis factor-alpha (rTNF) had minor effects on basal EC proliferation, but significant inhibition was observed in the presence of ECGF. A combination of rIFN-gamma and rTNF induced marked suppression of EC proliferation, which appeared to be due to a cytotoxic effect on the EC, as demonstrated by 51Cr release. In contrast, the combination of rIFN-gamma and rIL-1 had only an additive effect on EC proliferation, with no evidence of cytotoxicity. These results suggest that cytokines have important regulatory roles in local vascular proliferation. These effects varied not only with the individual cytokine, but also with the combination of cytokines used. The most striking effects were 1) the stimulation of proliferation by IFN-gamma at a low concentration and 2) the inhibition by both rIL-1 and rTNF of ECGF-stimulated proliferation.


Subject(s)
Cell Division/drug effects , Endothelium, Vascular/cytology , Interferon-gamma/pharmacology , Interleukin-1/pharmacology , Tumor Necrosis Factor-alpha/pharmacology , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Drug Synergism , Fibroblasts/cytology , Heparin/pharmacology , Humans , In Vitro Techniques , Neovascularization, Pathologic , Recombinant Proteins
SELECTION OF CITATIONS
SEARCH DETAIL
...